Analytic Investors’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$676K Hold
7,198
0.01% 433
2016
Q2
$775K Buy
7,198
+50
+0.7% +$5.86K 0.01% 411
2016
Q1
$858K Hold
7,148
0.01% 419
2015
Q4
$851K Buy
7,148
+3,446
+93% +$445K 0.01% 423
2015
Q3
$631K Hold
3,702
0.01% 425
2015
Q2
$718K Buy
3,702
+1,883
+104% +$350K 0.01% 418
2015
Q1
$270K Buy
+1,819
New +$277K ﹤0.01% 498
2013
Q4
Sell
-773
Closed -$87K 583
2013
Q3
$87K Sell
773
-2,272
-75% -$258K ﹤0.01% 499
2013
Q2
$344K Buy
+3,045
New +$372K 0.01% 483

Other funds holding SRGA

Analytic Investors's SRGA Position: Q3 2016 in Review

Analytic Investors held its Surgalign Holdings, Inc. Common Stock (SRGA) position steady in Q3 2016 at 7,198 shares worth $676K. The position accounts for 0.01% of the portfolio, ranked #433.

Analytic Investors first reported a position in SRGA in Q2 2013 and has held it in 9 quarters since. The position peaked at $858K in Q1 2016. 110 funds tracked by Wall St. Rank hold SRGA as of Q3 2016.

  • Analytic Investors held 7,198 shares of Surgalign Holdings, Inc. Common Stock worth $676K as of Q3 2016.
  • Analytic Investors left its Surgalign Holdings, Inc. Common Stock share count unchanged in Q3 2016.
  • Surgalign Holdings, Inc. Common Stock made up 0.01% of Analytic Investors's portfolio in Q3 2016, its #433 holding.
  • Analytic Investors first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and has held it in 9 quarters since.
  • Analytic Investors's Surgalign Holdings, Inc. Common Stock position peaked at $858K in Q1 2016.
  • 110 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.